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ABSTRACT 
 
In the present work, a 2D-capLC-ESI-TOF-MS method for fractionation and separation 
of peptides in microdialysates is demonstrated. Both comprehensive and quantitative 
analysis was conducted. The microdialysates samples (335 µL) were loaded onto a 1 mm 
x 5 mm loading column packed with 5 µm Kromasil C18 particles by a carrier solution of 
0.1 % formic acid in ACN/H2O (5/95, v/v) at a flow rate of 100 µL/min. Back-flushing 
onto a fractionating 0.32 mm x 150 mm ZIC-HILIC column packed with 5 µm particles 
was performed using a decreasing linear solvent ACN/H2O gradient containing 10 mM 
ammonium acetate at pH 6.8. Dilution of the effluent was done using a solution 
containing 0.1 % formic acid prior to on-line collection of fractions onto multiple 1 mm x 
5 mm Kromasil C18 column packed with 5 µm particles. Back-flushed elution of the 
fractions onto a 0.3 mm x 150 mm PLRP-S column packed with 3 µm particles was 
performed using an increasing stepped solvent ACN/H2O gradient containing 0.1 % 
formic acid. Positive ESI was performed in the m/z range of 200-1500. A post-column 
standard was introduced to MS detection when performing target compound analysis. 
The estimated concentration limit of detection (cLOD) was 0.15 ng/mL.
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ABBREVIATIONS  
 
µLC  Micro liquid chromatography 
ACN  acetonitrile 
BPI  base peak intensity 
capLC  capillary liquid chromatography 
cLOD  concentration limit of detection 
cLOQ  concentration limit of quantification 
EIC  extracted ion chromatogram 
ESI  electrospray ionization 
f.a.  formic acid 
f.s.  fused silica 
HILIC  hydrophilic interaction liquid chromatography
HPLC  high performance liquid chromatography 
I.D.  inner diameter 
LC  liquid chromatography 
LLE  liquid-liquid extraction 
m/z  mass to charge ratio 
mLOD  mass limit of detection 
mLOQ  mass limit of quantification 
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MP  mobile phase 
MS  mass spectrometry 
nanoLC  nanocolumn liquid chromatography 
NP  normal phase 
PEEK  polyetheretherketone 
RP  reversed phase 
RPC  reversed phase chromatography 
RSD  relative standard deviation 
S/N  signal to noise ratio 
SCX  strong cation exchange 
SPE  solid phase extraction 
THF  tetrahydrofuran 
TFA  trifluoro acetic acid 
TIC  total ion current 
TOF  time-of-flight 
UV  ultraviolet 
WCX  weak cation exchange 
ZIC  zwitterionic 
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1. INTRODUCTION 
1.1 Background 
 
Neurotransmitters constitute a group of compounds that mediate signaling between 
neurons and non-neuronical cells. Living organisms depend on a finely tuned balance 
between these compounds. Even a slight variation can cause diseases like depression, 
schizophrenia and other disorders. Neurotransmitters are divided in three main groups; 
amino acids, biogenic acids, and neuropeptides [1]. Studying the activity of these 
compounds much knowledge about the nature of different physiological conditions can 
be obtained. Bradykinin is a neuropeptide from a group called kinins. Kinins are peptide 
hormones that play a role in inflammation, blood pressure regulation, coagulation and 
pain [2]. Bradykinin is a kinin which besides the mentioned properties also increases 
glucose metabolism [3-6] and capillary vessel permeability [3]. Release is known to 
happen under high muscle activity [5]. As increased levels of bradykinin tell that an 
inflammation is taking place it may be an indicator of ill medical conditions such as 
chronic congestive heart-failure [7, 8]. Monitoring of kinins is useful for study of the 
various mechanisms in which they occur. Figure 1 illustrates the structure of bradykinin. 
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Figure 1. Structure of bradykinin [9] 
 
Several methods have been developed for the determination of peptides in mice [10], rats 
[11], humans [5, 12] and protein digest and peptide standard solutions [13, 14]. Saliva 
[15, 16], urine [12], plasma [17] and microdialysates [4, 11, 18, 19] are the most common 
matrices. In a recent study [4] bradykinin and kallidin was detected in microdialysis 
samples collected from human muscle tissue using an immunoassay technique with 
specific antibodies for each analyte. A similar study [11] used capillary column-switching  
liquid chromatography (LC) coupled with mass spectrometry (MS) to detect arg-
bradykinin and bradykinin in microdialysates. Due to the complexity of biological 
samples it is often required to employ methods with high resolving power such as two 
dimensional liquid chromatography (2DLC) to obtain satisfactory separation. Several 
2DLC methods have been developed for peptide [11, 12, 20, 21] and protein [15] 
separation. In essence, this type of methodology enables two types of chromatography to 
resolve the compounds in a sample. Fractions are collected from the first dimension, and 
the compounds contained in each fraction are then separated using a different type of 
chromatographic principle. As analyte concentrations are low, sensitive detection like 
mass spectrometry (MS) must be employed. For the same reason a preconcentration step 
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is often a necessity. This has been done using liquid-liquid extraction (LLE) [10], but 
solid phase extraction (SPE) is more commonly used in LC applications. For peptide 
separation in the first dimension, size exclusion chromatography (SEC) [22, 23], strong 
cation exchange (SCX) [24-27] and hydrophilic interaction liquid chromatography 
(HILIC) [20, 28-30] have been mainly applied. Mostly reversed phase (RP) 
chromatography [12, 15, 20, 21, 27, 31] is used in the second dimension. 2D-RP-RP 
peptide separation has also been conducted [32]. RP is the most common applied 
separation principle.  
 
1.2 Separation by SCX, HILIC and RP 
 
In SCX chromatography analytes are retarded by ionic interactions. The analytes are 
separated by charge. Higher charge yields greater retention. The functional group on the 
stationary phase (SP) in a SCX column is a strong acid residue chemically bound to a 
polymer or silica particles. Mostly sulfonic acids are used and they remain charged over 
the entire pH range. To attain retention, the pH of the mobile phase (MP) must be chosen 
as to maintain charge of the analytes. The retention of the analytes also depends on the 
ion strength of the buffered MP decreasing with increasing MP ion strength. For peptides 
the pH of the MP should be in the acidic range. The analytes are introduced in a low salt 
concentration MP. At such conditions the analytes change place with the counter ion, 
thus ion exchange, and are retained. Elution is performed by increasing pH, the salt 
content or a combination of both. It is more common to apply a salt gradient (20 to 500 
mM) as pH gradients are more difficult to reproduce. An organic modifier is often added 
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to the MP to suppress hydrophobic interactions between the analytes and the hydrophobic 
sites on the SP. 
 
 
 
Figure 2. The functional group on the ZIC-HILIC packing material [33] 
 
HILIC is variant of normal phase (NP) chromatography where an aqueous MP containing 
a high percentage of organic solvent is used. The SP is hydrophilic with zero net charge. 
In this study a zwitterionic (ZIC)-HILIC column was employed. The SP consists of a 
zwitterionic group chemically bound to silica particles. Figure 2 depicts the functional 
group of a ZIC-HILIC column. As the name states, analytes are retarded by hydrophilic 
interactions. Because the column has zero net charge only a low amount of salt or buffer 
is used in the MP. Normally 10 mM will suffice for peptides. Elution can be performed 
with a decreasing organic gradient or increasing salt/buffer content. The elution order is 
from less to more hydrophilic analytes. The most important consideration regarding 
HILIC is the orthogonality with reversed phase chromatography (RPC). This simply 
means that the elution order is the opposite of each other. Analytes that are not retained 
on a HILIC column will be retained on a RP column, and vice versa. If a 2D-plot is made 
from HILIC and RPC separations of a sample, true orthogonality is obtained if the plot 
reveals no correlation [34]. The concept of orthogonality is described in figure 3. 
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Figure 3. Geometric orthogonality concept. Hypothetical separation of 100 analytes in a 10 x 10 
normalized separation space. (A) Nonorthogonal system, 10 % area coverage represents 0 % 
orthogonality. (B) Hypothetical ordered system, full area coverage. (C) Random, ideally 
orthogonal, system. Area coverage is 63 % representing 100 % orthogonality. [34] 
 
 
RPC is the most common type of chromatography and is frequently used for separating 
peptides in both one dimensional (1D)LC [11] and 2DLC [12, 15, 20, 21, 31]. Retention 
on a RP column is due to hydrophobic interactions between the analytes and the SP. The 
most common SP consists of long alkyl chains chemically bonded to a polymer or silica 
particles. Various chain lengths exist (C1 to C18) whereas C18 materials are of the most 
frequently applied. Increasing organic content in the MP decreases retention. Elution 
order is from less to more hydrophobic. Samples are subjected to the RP column at low 
organic conditions, and typically an increasing organic gradient is used to elute the 
analytes. The organic solvents used must be water miscible [35]. Typical solvent used are 
acetonitrile (ACN), methanol and tetrahydrofuran (THF) [35]. Additives, such as 
trifluoro acetic acid (TFA) and formic acid (f.a.), are added to the MP in small amounts 
(< 1%, v/v) for several reasons. Adding a modifier increases retention and peak shape for 
ionic compounds by the formation of ion-pairs [36], and suppresses ionic interactions 
with residual silanol groups on silica based columns. 
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1.3 Microdialysis 
 
The samples analyzed in this study were collected microdialysates. It is a miniaturized 
form of dialysis where a probe is inserted directly into the tissue [6]. The probe only 
collects the compounds that pass through a membrane. The samples for this project were 
collected using a membrane with a cut-off value of 15 kDa. But the cut-off value is not 
accurate in the sense that all the compounds with higher masses than 15 kDa are 
excluded. The cut-off is defined as the molecular mass at which 80 % of the molecules 
are prevented from passing through the membrane [18]. The probe is perfused with a 
physiological solution consisting of e.g. Ringer acetate. The analytes distribute equally 
between the carrier solution and the surrounding tissue. Due to the extremely low 
concentration of analytes [5, 6, 17] and complexity of the sample, methods with high 
separating power and sensitivity must be utilized in order to obtain satisfactory detection 
of the analytes in the microdialysates. 
 
1.4 Capillary liquid chromatography (capLC) 
In analytical LC the amounts of analytes is often so low that detection is difficult to 
achieve unless extensive sample preparation must be performed to obtain detection. 
Using a narrower column presents several advantages over a larger bore column. There 
are several classes of column depending on their internal diameter (I.D.) presented in 
table 1. The most important advantage of downscaling the column I.D. is the increased 
mass sensitivity due to less volumetric dilution of the chromatographic band in the 
column. If the same amount of analyte is introduced into a conventional column (4.6 mm 
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I.D.) and a capillary column (0.32 mm I.D.), the capillary will have a theoretical mass 
limit of detection (mLOD) ~200 times lower than the conventional column [37]. The 
dilution D of an injected sample is given by; 
 ( )( )
1
2 21 2 end
inj inj
r k L H CD
V C
ε π π+= =    (1.1) 
Equation 1.1 contains parameters where ε is the column porosity, r is the column internal 
radius, k is the retention factor, L is the column length, H is the plate height, and Vinj is 
volume injected. The reduction of column size requires lesser amounts of sample, which 
is convenient in biological analysis when samples often are in limited amount. The lower 
flow in a capillary (down to 1 µL/min) simplifies the use MS detection because of the 
small amount of solvent required to evaporate. Lower solvent and stationary phase 
consumption is a profitable affair.  
 
Table 1. Classification of LC columns according to the internal diameter (I.D.) 
Column class Internal diameter [mm] 
Conventional 3 - 5 
Narrow-bore 2 
Micro bore 0.5 - 1 
Capillary 0.1 - 0.5 
Nano 0.01 - 0.1 
Open tubular 0.005 - 0.05 
 
 
1.5 Electrospray ionization mass spectrometry (ESI-MS)  
For compounds to be detected in the MS, they must first be ionized. In this project 
electrospray ionization (ESI) was utilized since peptides are easily ionized to cations due 
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to their basic residues. ESI is a so-called soft-ionization technique, which provides little 
or no fragmentation of the analytes. Voltage is applied over the tip of an f.s. capillary 
needle. An additional gas flow axially with the needle is needed to assist the nebulization. 
An ideal spray has the shape of a Taylor cone [38]. A volatile salt/buffer should be 
present in the MP to provide conductivity, which in turn assists in the formation of 
charged droplets. The existence of organic solvent reduces the surfaces tension to aid 
droplet formation and solvent evaporation. The fine jet of solvent produced at the spray 
capillary disintegrates into charged droplets with a diameter of circa 1 µm. Solvent 
evaporation from the droplets occur to a point where the droplets reach the Rayleigh 
limit, which specifies the maximum charge a spherical droplet can hold before the 
Coulomb repulsion overcomes the surface tension. The droplets then undergo an uneven 
fission where they eject about 20 offspring droplets each. The offspring droplets are 
about one order of magnitude smaller than their mother droplets and include about 15 % 
of their charge and about 2 % of their mass. Subsequent evaporation and uneven fission 
of the droplets continues, creating second-generation droplets [38]. As the droplets 
continue into the MS, they are further desolvated until gas phase ions are formed and 
detected by the MS. 
 
1.6  Aim of study 
 
The purpose of this study was to develop a sensitive on-line 2D-LC method with high 
resolving power for determination of peptides in complex matrices, both for 
comprehensive and target compounds. The method will be optimized in microdialysis 
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samples. One of the goals, despite the intricacy of 2D systems, is to create a system that 
is robust and relatively easy in operation. 
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2. EXPERIMENTAL 
 
2.1 MATERIALS AND REAGENTS 
 
HPLC grade acetonitrile (ACN) was obtained from Rathburn Chemicals Ltd. 
(Walkerburn, UK). Grade 1 water was provided by a Milli-Q ultrapure water purification 
system (Millipore, Bedford, MA, USA). Ammonium acetate (NH4Ac, purum), 
ammonium formate (NH4formate, MS grade) and formic acid (f.a. 50%, HPLC grade) 
were purchased from Fluka (Buchs, Switzerland). NaCl (≥ 99.5 %, analytical grade) was 
purchased from Sigma Aldrich (St.Louis, MO, USA). AnalR grade ammonia (25 % NH3 
solution, 13.4 M) was acquired from BDH Chemicals Ltd. (Poole, UK). Hydrogen 
chloride (HCl) 37 % solution (analytical grade) was purchased from Merck KGaA 
(Darmstadt, Germany). Purum quality sodium hydrogen carbonate (> 99.3 % NaHCO3) 
was obtained from KEBO Lab AB (Spånga, Sweden). Bovine albumin (≥ 97 %, gel 
electrophoresis), chicken egg albumin (99 %, gel electrophoresis), rabbit hemoglobin 
(Hb), human transferrin (≥ 98 %) and Apolipoprotein A (Apo A) were purchased from 
Sigma Aldrich GmbH (Steinheim, Germany). Bradykinin, angiotensin II, oxytocin and 
thyrotropin-releasing hormone (TRH) were acquired from Fluka. Fused silica capillaries 
were purchased from Polymicro Technologies Inc. (Phoenix, AZ, USA). Helium (≥ 
99.996 %) and nitrogen (99.99 %) were purchased from AGA AS (Oslo, Norway). 
Microdialysis samples from rat muscle were obtained from the National Institute of 
Public Health, Oslo, Norway. Fractionating column materials were PolyLC 
 18
Polysulfoethyl Aspartamide (PolyLC Inc., CO, USA) and ZIC-HILIC (SeQuant, Umeå, 
Sweden), both with particle size of 5 µm. The pore size was 300 Å and 200 Å for PolyLC 
and ZIC-HILIC, respectively. The PolyLC (1 x 150 mm ) column was purchased from 
G&T Septech (Kolbotn, Norway). The TSK-Gel Amide 80 (5 µm, 80 Å) column (1 x 50 
mm) was obtained from Tosoh Bioscience GmbH (Stuttgart, Germany). Pre- and trap 
columns (1 x 5 mm) packed with Kromasil C18 (5 µm, 100 Å) and a PLRP-S polystyrene-
divinylbenzene (PS-DVB) (3 µm, 300 Å) column (0.32 x 150 mm) were obtained from 
G&T Septech. A Jupiter Proteo C12 (4 µm, 90 Å) column (0.32 x 150 mm) was obtained 
from Phenomenex (Aschaffenburg, Germany). A Chromolith CapRod C18 (2 µm, 130 Å) 
monolithic column (0.1 x 150 mm) was purchased from Merck. Bulk Kromasil C18 (3.5 
µm, 100 Å) packing material was purchased from G&T Septech.  
 
Stock solutions of angiotensin II and bradykinin (1 mg/mL) were made by dissolving 25 
mg of each compound in 25 mL water, and transferred to 1.5 mL polypropylene micro 
centrifuge tubes (Brand GmbH, Wertheim, Germany) in 1 mL aliquots for storage at -
18ºC. A mixture of five peptides containing 0.1 mg/mL angiotensin II, 0.05 mg/mL 
bradykinin, 0.1 mg/mL leucine enkephaline, 5 µg/mL oxytocin and 0.2 mg/mL, was used 
in preliminary testing of the fractionating columns. 
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2.2 SAMPLE PREPARATION 
 
2.2.1 Protein digests 
 
A 1 M solution of NaHCO3 was prepared by dissolving 8.4014 g of the latter compound 
in 100 mL water. A 1 M NH3 solution was made by diluting 7.462 mL (25 % / 13.4 M) 
NH3 to a volume of 100 mL. A 25mM ammonium hydrogen carbonate (NH4HCO3) 
buffer was composed by mixing 2.5 mL 1 M NH3 and 2.5 mL 1 M NaHCO3 and dilution 
to a volume of 100 mL. The buffer was titrated to pH 7.5 using some drops of 
concentrated HCl. A 2 mg/mL trypsin solution was prepared by dissolving 4 mg trypsin 
(Promega, Mannheim, Germany) in 2 mL NH4HCO3. Separate protein digest solutions 
containing bovine albumin, chicken egg albumin, rabbit hemoglobin and human 
transferrin were made for column and system testing. 1 mg of each protein were weighed 
into individual 1.5 mL polypropylene tubes (Brand GmbH, Wertheim, Germany), then 
250 µL NH4HCO3 buffer and 25 µL 2 mg/mL trypsin solution was added. The tubes were 
incubated at 37°C for 24 hours and then stored at -18°C as stock protein trypsinates. 
These trypsinates were thawed and 750 µL NH4HCO3 buffer was added before use, 
resulting in a total volume of 1 mL. Additionally a mixture of three trypsinated proteins 
(bovine albumin, human transferrin, rabbit hemoglobin) was prepared by mixing 250 µL 
of each protein trypsinate solution and adding 250 µL NH4HCO3 buffer. This solution 
will further be referred to as XXX. 
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2.2.2 Microdialysis samples 
 
Fifteen samples were collected by microdialysis in rat thigh muscle in aliquots of 600 µL 
into 1.5 mL polypropylene tubes. Two of the delivered samples had a volume of ~300 
µL. The carrier solution was Ringer acetate and the membrane in the microdialysis probe 
had a cut-off value equal to 15 kDa. The microdialysates were stored at -18°C. Each 
sample was thawed at ambient temperature prior to analysis. The sample material to be 
analyzed was collected by Fernando Boix from the National Institute of Public Health 
(Oslo, Norway). Prior to injection each sample was centrifuged at 3000 rpm for 10 
minutes, using a Biofuge centrifuge (Heraeus instruments, Hanau, Germany).  
 
2.2.3 Calibration solutions 
 
A 10 µg/mL bradykinin solution was made by transferring 1.0 mL of bradykinin (1.0 
mg/mL) to a 100.0 mL volumetric flask and diluting with 0.1 % f.a. solution. An aliquot 
of this solution was transferred to a 20 mL polypropylene (VWR, Oslo, Norway) vial and 
used to prepare bradykinin calibrations solutions containing 0.025, 0.25, 2.5 and 5 
µg/mL. All solutions contained 0.05 % formic acid. A calibration curve was obtained by 
injecting 2 µL with 0.025, 0.25, 2.5 and 5 µg/mL solutions corresponding to 0.05, 0.5, 
2.5 and 10 ng of bradykinin, respectively. 
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2.3 COLUMN PREPARATION 
 
The fractionating capillary columns were slurry packed using a downward high pressure 
method developed in-house [39]. Carbon tetrachloride was used as solvent for the slurry. 
The stationary phases used were PolyLC, ZIC-HILIC and Kromasil C18. Fused silica 
capillaries, 320 µm internal diameter (I.D.) and 450 µm outer diameter (OD), and 0.5 mm 
I.D. steel tubing, served as column bodies, all of 15 cm length. PolyLC was also packed 
in 0.5 mm I.D. x 12.5 cm steel tubing. Valco (Valco Instruments, Houston, TX, USA) 
ZU1C unions, Valco FS1.4 polyimide ferrules and Valco 2SR1 steel screens were used 
for the end fittings. 
 
2.4 CHROMATOGRAPHIC SYSTEM 
 
 
2.4.1 Preliminary test system 
 
A preliminary test system was assembled to examine the PolyLC (0.5 mm x 10 cm, 1 mm 
x 15 cm) columns. Loops of 1, 2, 5, and 50 µL were used for sample introduction using a 
6-port Valco valve (Val.1). Sample was loaded onto a C18 SPE (1 x 5 mm). The load MP 
(ACN/H2O [5/95, v/v] containing 0.1 % f.a.) was delivered by a Hitachi L-7100 (Hitachi 
High-Technologies Corporation, Tokyo, Japan) isocratic pump. Elution was performed 
by switching a second 6-port Valco valve (Val.2) and back-flushing the SPE using a 
linear salt gradient from 2 to 100 % B in 10 minutes. Solvent A was constituted of 
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H20/ACN (75/25, v/v) containing 0.1 % TFA. Solvent B constituted of A + 500 mM 
NaCl. Both solvents had a pH of 2. The gradient MP was delivered using an Agilent 1100 
Series capillary gradient pump (Agilent, Palo Alto, CA, USA) with an incorporated on-
line vacuum degasser. UV detection was done with a 100 UVIS detector (Spectra-
Physics, Fremont, CA, USA) equipped with a 100 µm I.D. on-capillary flow cell. Data 
acquisition was done at 220 nm and 254 nm using Totalchrom 6.2.1. All connections 
were done using fused silica (f.s.) with I.D. of 75 µm. Figure 4 shows the instrumental 
arrangement. 
 
 
Figure 4. The preliminary instrumental setup 
 
2.4.2 First dimension (µSPE-capLC-UV) 
 
Figure 5 depicts the entire instrumental arrangement. The dashed line points out the first 
dimension, which is a column switching system. The sample was loaded onto a Kromasil 
C18 SPE (1 x 5 mm) column by use of a Hitachi L-7100 isocratic pump (PUMP1). The 
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loading mobile phase (ACN/H2O [5/95, v/v] containing 0.1 % f.a.) was delivered, at a 
flow rate of 100 µL/min. Back flushing of the SPE column was performed using a linear 
gradient delivered at 5 µL/min by an Agilent 1100 Series capillary gradient pump with an 
incorporated on-line vacuum degasser (PUMP2). The gradient ran from 85 % to 45 % B 
in 30 minutes followed by a 10 minute wash with 45 % B. Solvent A consisted of 10 mM 
NH4Ac. Solvent B consisted of ACN/H20 (98/2, v/v) and 10 mM NH4Ac. The pH in both 
solvents was 6.8. Two Valco Cheminert 6-port two-position valves were used for sample 
introduction and column switching. A 335 µL sample loop (0.5 mm I.D. steel) was 
connected to valve 1 (V1). The C18 SPE column was coupled to valve 2 (V2). Pump 1 
and pump 2 were connected to valve 1 (V1) and 2 (V2), respectively. Detection was done 
using a Spectra 100 UVIS detector equipped with a 100 µm I.D. on-capillary flow cell. 
Data acquisition was performed at 220 nm using Totalchrom 6.2.1. The fractionating 
fused silica capillary column (0.32 x 150 mm) was packed with ZIC-HILIC stationary 
phase. Remaining connections were made with 75 µm I.D. fused silica, except for the 
capillary in the UV detector which was 100 µm I.D. due to the requirement of detection 
path length. Fused silica connections were made using Valco ZU1C unions and Valco 
FS1.4 polyimide ferrules. 
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Figure 5. Diagram of the instrumental setup 
 
2.4.3 Second dimension (µSPE-capLC) 
 
The effluent from the UV detector was diluted with 0.1 % f.a. delivered by a Hitachi L-
7100 isocratic pump (PUMP3), using a Valco T-connection. Pump 3 delivered the 
diluting solution (0.1% f.a.) at a flow rate of 70 µL/min, resulting in a 15x dilution. The 
resulting dilute was transferred to the C18 SPE columns. This was achieved by coupling 
two column carousels in series, equipped with 9 C18 SPE columns each. That gives 18 
SPE columns in total for collection of fractions. See figure 5 for graphical explanation. 
The two carousels were coupled to a Valco 6-port two position valve (V3). The latter 
valve and carousels were mounted on a metal plate. Each carousel consisted of two 
interconnected Cheminert C5 10-port stream selector valves mounted on one Cheminert 
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high torque (EMT) microelectric actuator (see Figure 6 for picture of the carousels). One 
port on each carousel was fitted with a bypass loop (75 µm I.D. f.s.). Switching valve 3 
permits back-flushing of the sample from the carousel(s) onto the analytical PLRP-S 
column (0.32 x 150 mm) with a stepped gradient delivered by an Agilent 1100 Series 
(PUMP4). Flow of the mobile phase was 5 µL/min. Solvent A and B consisted of grade 1 
water and ACN, respectively. Both reservoirs contained 0.1 % f.a. The gradient ran from 
5 % to 15 % B in 3 minutes, 15 % to 30 % B in 15 minutes and then from 30 % to 50 % 
B in 5 minutes. Finally the column was washed for 10 minutes with 90 % B (see Table 
2). Column conditioning was done using 5 % B for 20 minutes. Protein digests and UV 
detection was used in preliminary testing of the performance of the system, otherwise 
mass spectrometric (MS) detection was performed. 
 
Table 2: RP gradient timetable 
Time [min] % B 
0.01 5 
3.00 15 
18.00 30 
23.00 50 
23.01 90 
 
For sample screening purposes all the SPE columns on the carousels were used. When 
performing target analyte quantification only one of the SPE columns was used.  
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2.4.4 Target analyte quantification and comprehensive analysis 
 
For target analyte quantification a standard was introduced after the analytical column. 
This was achieved with a Valco 4-port valve with 500 nL internal loop just prior to MS 
detection. The standard (5 µg/mL bradykinin containing 0.05 % f.a.) was introduced into 
the MS, using V4, shortly after detection of the analyte peak. The last connection from 
V4 to the TOF-MS instrument was done using 63 µm I.D. polyetheretherketone (PEEK) 
tubing (Upchurch Scientific, Oak Harbour, WA, USA). 
 
 
Figure 6. Picture of the two column carousels in series, coupled to V3. Everything was 
mounted on a metal plate for added robustness and mobility. 
 
As soon as the analyte peak front, from the first dimension, was detected by the UV 
detector, the effluent flow was directed through one of the C18 SPE columns on the 
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carousels. Dilution of the effluent was necessary to achieve retention. The dilution pump 
diluted the effluent 15 times so that the ACN percentage was 5.7 to 3 throughout the 
HILIC gradient. Kromasil C18 (5 µm particles) trapcolumns were employed to 
accommodate the high flow and avoid too high back-pressure. The smaller particles in 
the analytical RP (3 µm particles) column provided refocusing when back-flushing the 
trap columns onto the analytical RP column. 50 µL of XXX solution was introduced onto 
the C18 SPE and back flushed onto the ZIC-HILIC column. The sample was divided into 
8 parts using only one carousel, thus collecting each fraction for 3 minutes before 
switching the flow over to a new SPE. For comparison a similar screening was done but 
instead using all 19 SPE columns, thus collecting each fraction for 1.5 minutes. Each 
fraction was then eluted onto the analytical RP using a stepped gradient described in 
section 2.4.2. UV detection at 220 nm was used in both cases. 
 
2.4.5 Detection (ESI-TOF-MS) 
 
Detection in the second dimension was done using a Micromass LCT TOF-MS (Waters, 
Manchester, UK) equipped with a Z-spray atmospheric pressure electrospray ionization 
(ESI) ion source. The electrospray was operated in positive mode. The voltages applied 
over the capillary, sample- and extraction cone are shown in table 3. See appendix 6.5 for 
more parameter details. 
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Table 3. Applied MS-voltages 
  Voltage [V]
Capillary 3200
Sample Cone 11
Extraction Cone 3
RF Lens 500
 
Desolvation and source temperature were both set at 110°C. The desolvation gas flow 
rate was adjusted to ~300 L/h. Data were acquired in the mass-to-charge (m/z) interval 
200 – 1500 using MassLynx 4.0 (Micromass). Calibration of the instrument was done 
using a sodium/caesium iodide solution (2 µg/mL) dissolved in isopropanol/water (50/50, 
v/v).  
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3. RESULTS AND DISCUSSION 
 
In 2DLC there are two main techniques, comprehensive chromatography and heart- 
(/front-/end-) cutting. A 2D separation is considered comprehensive if every part of the 
sample is subjected to two different separations, each with a different characteristics, 
whereas in heart cutting only one fraction from the first dimension is subjected to 
separation in the second dimension [40, 41]. The amounts of peptides present in 
microdialysis samples are relatively low [11]. 2DLC in combination with column 
switching provides the required sensitivity and selectivity to detect peptides present at 
very low concentrations. The use of large volume injection further lower the detections 
limits [11], given there is sufficient amount of sample. 
 
 
3.1 Comprehensive analysis 
a. Method development 
1. First dimension 
The columns used in a 2DLC system should provide orthogonal separation for obtaining 
the best resolution of complex samples. UV and TOF-MS detection were both used for 
testing the columns in the first dimension. Two different types of SP were employed for 
fractionation; SCX (PolyLC) and HILIC (ZIC-HILIC and TSK-Gel). The choice of 
mobile phase for the SCX column was based upon a previous study [42]. A linear salt 
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gradient (20 to 500 mM NaCl) at pH 2 was used. A mixture of peptides was introduced 
onto the PolyLC column in preliminary experiments (Appendix 6.4). Angiotensin II and 
bradykinin standards were introduced in the preliminary experiments. Narrow peaks (~ 
0.5 min) of both angiotensin II and bradykinin appeared, but the compounds were not 
fully separated. Exchanging NaCl with NH4-formate did not provide separation. However 
peak broadening and severe peak fronting, due to SP collapse, were observed after some 
time. The column collapse could be due to bad packing of the SP. Hence different slurries 
were explored for packing of the SCX column. Solvents used for slurries were carbon 
tetrachloride, H20/MeOH (50/50, v/v) and MeOH. However, SP collapse was observed 
for all slurries. A commercial column also exhibited serious SP collapse. Instability of 
this particular SP has also been observed in a previous study [43]. No reasonable 
explanation was found for this behavior therefore the use of SCX columns was 
discontinued from use. 
 
The types of HILIC columns that were tested for the first dimension were ZIC-HILIC 
(0.32 x 150 mm) and TSK-Gel Amide 80 (1 x 5 mm). Elution on both HILIC columns 
was carried with a linear gradient from 85 to 45 % ACN containing 10 mM NH4Ac. 
Despite the fact that NH4Ac is not UV transparent at 220 nm, the low concentration does 
provide detection of peptides at concentrations which do not overload the column. The 
volatile salt is fully compatible with electrospray ionization (ESI)-MS detection. 
 
The TSK-Gel HILIC column displayed varying retention times and peak sizes. 
Reproducibility could not be achieved even after extended periods of column 
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conditioning. Air spikes were initially observed while using the TSK-Gel HILIC column. 
The latter types of columns are very vulnerable to air passing through them. Air bubbles 
will most certainly create channels in the column bed and render it chromatographically 
destroyed, which may have been the case in this situation. After this discovery the TSK-
Gel HILIC column was discontinued from use. 
 
The ZIC-HILIC column demonstrated adequate retention of peptides. Angiotensin II and 
bradykinin was well separated but tailing occurred to some extent (see Figure 7).  
 
 
Figure 7. Chromatogram of a solution of different peptides injected onto the ZIC-HILIC 
column (0.32 x 125 mm). The solution contained 0.1 mg/mL angiotensin II, 0.05 mg/mL 
bradykinin, 0.1 mg/mL leucine enkephalin, 5 µg/mL oxytocin and 0.2 mg/mL TRH. 50 
µL sample was loaded onto a C18 SPE (1 x 5 mm) using ACN/water (5/95, v/v) 
containing 0.1 % f.a. delivered at 50 µL/min. Elution was done with a gradient running 
from 85 to 45 % ACN containing 10 mM NH4Ac, in 20 minutes. Detection with UV at 
220 nm. 
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Gradient: 85% → 45% ACN  
  (10 mM NH4Ac) in 20 minutes 
Flow:  5 μL 
Injected: 50 μL loop (column switching) 
Detector: UV at 220nm 
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To attain stable retention times on the ZIC-HILIC column several cycles of gradients and 
injections of samples had to be completed. The retention of the peptides then increased to 
a constant value after several injections. Small amounts of the injected compounds tend 
to irreversibly adsorb to the metal frits in the column end fittings as well as on the 
column itself. Basic analytes in particular tend to bind irreversibly to the acidic rest-
silanol groups on the silica particles. Thus several injections must be performed to 
saturate the chromatographic system before stable operation is achieved. Operation of the 
ZIC-HILIC packing material in HILIC mode required a high amount of ACN in the MP, 
and therefore a dilution step was necessary prior to collection of fractions on the second 
dimension RP trap columns. In preliminary experiments a long column (23 cm) was 
utilized, but the length was reduced to 12.5 cm in order to obtain lower analysis time. 
Trypsinated albumin, apo A and the pre made XXX solution (trypsinated; bovine 
albumin, human transferrin, rabbit hemoglobin) were injected to establish a picture of the 
column performance with more complex samples. The goal was to achieve an even 
distribution of the sample content throughout the separation to attain adequate 
fractionation. Gradient times were varied to find the best distribution versus time (see 
figure 8). 
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Figure 8. Overlay BPI chromatograms of trypsinated apo A on a ZIC-HILIC column 
(0.32 x 125 mm). Sample introduction using column switching with Kromasil C18 
operculum (1 x 5 mm). Loading MP was 95/5 (ACN/H20, v/v) containing 0.1 % f.a. Loop 
size was 5 µL (upper chromatogram: 10 µL). Elution with linear gradient from 85 to 45 
% ACN containing 10 mM NH4Ac delivered at 5 µL/min. Gradient time from top to 
bottom; 20, 30 and 40 minutes. Detection was performed with ESI-TOF-MS in positive 
mode. Acquisition was done from m/z 200 to 1500. 
 
 
A gradient time of 30 minutes proved to be the best compromise between resolution and 
analysis time. The retention of polar compounds on the ZIC-HILIC column was 
relatively high. In an effort to decrease retention and improve peak shape, elution at 
elevated column temperatures was assessed (see Figure 9). This did lower the retention 
slightly, but also the peak height did. The peak broadened as the temperature increased. 
Because no preheating of the MP was done, a temperature gradient in the cross section of 
the column (f.s. I.D. 0.32 mm) may have been created at the column inlet. In such a case 
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30 min 
40 min 
Time
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analytes travels faster near the column wall thus explaining the peak broadening [44]. 
Therefore further experiments were performed at ambient temperatures.  
 
The repeatability of the ZIC-HILIC column over a period of two subsequent days was 
tested using angiotensin II and bradykinin. The results are represented in Figure 10 and 
Table 4. 
 
Figure 9. Chromatogram of albumin trypsinate. Variations in retention times at equal 
temperatures are due to insufficient column conditioning. Gradient elution as described in 
figure 7 and 8. Injection loop with a volume of 500 nL was used. Gradient time was 30 
minutes. Detection was performed with UV at 220 nm.  
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  0,0 1,0 2,0 3,0 4,0 5,0 6,0 7,0 8,0 9,0 10,0 11,0 12,0 13,0 14,0 15,0 16,0 17,0 18,0 19,0 20,0  
 Figure 10. 0.83 µL of a 1 mg/mL solution of angiotensin II and bradykinin separated, in 
 that order, on a ZIC-HILIC (5 µm, 200 Å) column (0.32 mm I.D. x 23 cm) using a 
 decreasing organic gradient (ACN/water) containing 10 mM ammonium acetate in 
 20 minutes. Mobile phase flow at 10 µL/min. Two (lower traces) and three (upper traces) 
 replicates were performed on two subsequent days. 
 
  Table 4. Retention times and areas of angiotensin II and     
  bradykinin from the chromatograms in Figure 10. 
  Angiotensin II Bradykinin 
Run Rt [min] Area Rt [min] Area 
1 7.1 22471 16.3 32074 
2 7.0 22849 16.3 29086 
3 7.0 20651 16.4 21867 
4 7.1 30752 16.4 53821 
5 7.1 29457 16.4 52544 
Average 7.1 25236 16.4 37878 
STD 0.055 4544 0.055 14462 
RSD (%) 0.01 0.18 0.00 0.38 
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2. Second dimension 
 
UV and TOF-MS detection was used in examination of the column for the second 
dimension. RPC was decided to be employed in the second dimension since it provides 
good orthogonality with HILIC, as explained in section 1.2. Initially, a nano-RP column 
(100 µm I.D.) was supposed to be employed for the second dimension, but the TOF-MS 
used in this study was not fully optimized to function with nanoflow (>500 nL/min). An 
issue that could arise was the lower capacity of such a narrow column. Despite their 
lower capacity, a nanocolumn was tested. It was a monolithic silica based endcapped C18 
column (100 µm I.D.), providing low back pressure at elevated flow rates compared with 
packed columns with the same internal diameter. The flow through the monolith was set 
to 1 µL/min. The other columns examined were PLRP-S (0.3 mm I.D.) and Jupiter Proteo 
(0.3 mm I.D.). The PLRP-S is a PS-DVB polymer based column. The Jupiter Proteo is a 
silica based endcapped C12 column. Performance assessment was done by introducing 
tryptic apo A and comparing four closely eluting peaks viewed in an extracted ion 
chromatogram (EIC). Elution was done using a linear gradient running from 5 to 50 % 
ACN containing 0.1 % formic acid. In preliminary experiments TFA was used an 
additive, but TFA bind so strongly to the analytes that ion-suppression is likely to occur 
in the MS [45]. Instead formic acid was used as an additive. The three RP columns were 
examined by comparison of four closely eluting in a tryptic apo A solution (see Figure 
11). 
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Figure 11. EIC chromatograms of four closely eluting peaks in a tryptic apo A eluted 
through three different columns. Elution with a linear gradient from 5 to 50 % ACN in 15 
minutes, containing 0.1 % f.a. 
 
The gradient described in section 2.4.2, was based on an earlier in-house study [15]. 
Since most peptides elute in the interval 15 – 30 % ACN in a RP system the gradient 
slope in this area is the lowest with a rise at 1 % ACN/min. 
 
3. Sample introduction 
A sample loop with the proper volume had to be used. It was desirable to install a sample 
loop with a volume as large as possible, but using a too large loop could result in 
precolumn breakthrough and fractionation column overloading. For a loop to be 
homogeneously filled it should be overfilled at least three times its volume. Considering 
the rather limited amount of sample solution available, using a loop size to fulfill the 
latter statement would require a loop with a volume of 100 µL. This would compromise 
sensitivity, therefore a loop volume of 335 µL was employed. To introduce samples of 
Time
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such a volume, column switching was utilized with the use of a Kromasil C18 SPE 
column (1 x 5 mm). For sample loading an ACN/H2O (5/95, v/v) solution containing 0.1 
% f.a. was used, providing on-line sample desalting, enrichment and cleanup since many 
polar compounds were not retained on the C18 SPE. The combination with a HILIC 
column provides excellent sample refocusing prior to gradient elution in the first 
dimension. No other material was tested as Kromasil already possesses the qualities of 
providing low backpressure, permission of high loading rates and loadability. No 
breakthrough testing was performed as this has been performed in a similar previous 
study [11]. 
 
b. Application 
 
The full function of the instrumentation shown in figure 5 was tested using the conditions 
as described in section 2.4. In preliminary experiments the HILIC gradient was run from 
85 to 45 % B in 20 minutes. The decision to increase the gradient time to 30 minutes was 
taken after the functionality tests. At first the XXX solution was used to examine the 
resolution of the method. Selected fractions from the XXX solutions were collected at 
different fraction lengths (30 sec, 1.5 min, 3 min) (see Figure 12). Splitting one or more 
compounds of low relative abundance into two fractions may result in the peak(s) to be 
under their respective detection limits, with respect to the second dimension analysis. 
This is especially an important note regarding broadened peaks. The front peak from the 
first dimension contained compounds of such hydrophobic character that virtually no 
retention was reached in the first dimension. This peak had a width of ~1.5 minutes 
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which made up the first fraction. In an effort to split it up capturing was done every 30 
seconds, splitting the peak into three fractions (see Figure 12). 
 
Figure 12. Two individual separations of XXX (trypsinated; bovine albumin, human 
transferrin, rabbit hemoglobin) in the first dimension. One (A) was fractionated every 3 
minutes and the other (B) every 1.5 minutes. Peak #1 was split into fractions á 30 
seconds. Chromatographic conditions as explained in section 2.4.2 and 2.4.3. Sample 
loop was 50 µL. UV detection done at 220 nm. 
 
The second dimension RP separation of the fractions marked in red are shown in Figure 
13. The observed time differences between the two chromatograms in figure 12 originate 
from too short column conditioning. At this stage it is of no particular importance as the 
objective was to examine the separation power of the method. Figure 14 shows the effect 
of splitting a peak (A: fraction 3) into two parts (B: fractions 5 and 6). 
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Figure 13. Fraction 1 from figure 12 chromatographed in the second dimension. Upper: 
Fraction 1 after splitting in three. Lower: Fraction 1 without any splitting. Chromatographic 
conditions as described in section 2.4.2. and 2.4.3. UV detection done at 220 nm. 
 
8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
Front peak captured
every 30 seconds 
into three fractions 
Front peak as one
entire fraction 
10
12
14
16
18
20
22
24
26
28
30
32
34
36
38
8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
 41
 
Figure 14. Second dimension of the fractions corresponding with the numbering in figure 12. 
Chromatographic conditions same as in figure 11.UV detection at 220 nm. 
 
The chromatographed XXX divided into 1.5 minute fractions were combined in a 2D-
plot to graphically illustrate the sample content (see Figure 15). The second dimension in 
the plot starts at 10 minutes because the gradient delay is ~10 minutes. 
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Figure 15. 2D-plot (HILIC-RP) of a XXX sample fractionated at 1.5 minute intervals. 
The x- and y-axis represent the retention time in the first and second dimension, 
respectively. The second dimension is plotted from 10 minutes due to the 10 minute 
gradient delay. Detection performed with UV at 220 nm. (Figure prepared by Gabriel 
Vivo Truyols, University of Amsterdam) 
 
Figure 15 illustrates the distribution of the compounds in the sample. The first HILIC 
fraction contains the most hydrophobic compounds, not retained in the first dimension. 
The common bands that appear in more than one fraction may or may not be the same 
compound or group of compounds. By utilizing a MS detector in the second dimension 
the content in the bands can be determined. A rat brain extract was subjected to 
comprehensive analysis utilizing ESI-TOF-MS was used for detection in the second 
dimension, but was not completed due to instrumental difficulties (results not shown). 
Tryptic apo A was separated on both HILIC and RP columns to examine the 
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orthogonality. A number of representative m/z values from a tryptic apo A were chosen 
and ion masses were calculated to confirm that no m/z values originated the same ion. 
The m/z values were plotted in 2D-plot (Figure 16) which reveals that the orthogonality 
of the method is satisfactory. The numbers in figure 16 represent the mass of the 
respective compounds. The charge of the compound is shown in figure 17.  
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Figure 16. 2D-plot of selected masses from a tryptic apo A solution eluted through a 
ZIC-HILIC column and a PLRP column. The bubble sizes are relative to the respective 
ion masses calculated from table 9 (Appendix 6.1).Sample introduced by column 
switching using 5 µL loop and ACN/H20 (5/95, v/v) containing 0.1 % f.a. as loading MP. 
Chromatographic conditions, 1st dimension; as in figure 8 using 30 minute gradient, 2nd 
dimension; Gradient ran from 5 to 50 % ACN in 15 minutes. Detection for both 
dimensions was ESI-TOF-MS. 
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 Figure 17. The distribution of charge. Small dots: charge +1, big dots: charge +2. 
 Same conditions as in figure 16.  
 
 
 
3.2 TARGET COMPOUND ANALYSIS 
a. Method development 
1. First and second dimension 
 
When performing a quantification analysis either an internal or external standard is 
normally used. Standards are necessary to establish a calibration curve from which the 
amount of target analyte(s) may be calculated.  External standards are used when the 
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chromatographic conditions are constant when performing sample analysis and that the 
injected volumes are precise. A calibration curve is established by plotting the standard 
area, of the target analyte(s), as a function of amount or concentration. An internal 
standard (I.S.) is a known amount of a compound that is added to the sample matrix prior 
to analysis. The area ratios between the analyte and I.S. in the sample is compared to the 
ratios from a calibration curve established with known amount of the target analyte and 
I.S. Using an I.S. will correct for sample loss, changes in injected volumes and other 
variations in the chromatographic conditions. In this study a combination of both 
techniques was used, further referred to as post-column standard (PC.STD.). Using this 
method, any variations in the response in the MS was compensated for as both the analyte 
and PC.STD. were introduced to the MS in a narrow time interval. The PC.STD. was 
introduced shortly after the standard was detected in the MS. The linearity of the MS was 
examined along with the establishment of the calibration curve. The calibration standard 
with the highest concentration level (5 µg/mL) appeared to exceed the linear range of the 
MS and was therefore removed from the calibration curve (see Figure 18). Raw data for 
the calibration curve is presented in Appendix 6.2 
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Figure 18. Plots of AreaStandard/AreaPC.STD. as a function of ng standard injected. Upper: All four 
standard solutions included. Lower: The solution with the highest concentration excluded 
 
 
The calibrations curve is expressed as AreaStandard/AreaPC.STD as a function of absolute mass 
of standard. To ensure that the method using PC.STD. was stable, bradykinin (2 µL 5 
µg/mL) was injected onto the PLRP column along with the PC.STD. (see table 5). The 
results in table 5 show that the peak areas of the standards fluctuate. Comparing the ratio 
between the standards reveals that any variations in response in the MS are compensated 
and that the technique is robust. 
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Table 5.  Four injections of 2 µL 5 µg/mL bradykinin on the PLRP column, and 500 nL 5 µg/mL 
with valve 4 (V4) each time. Gradient ran from 5 to 50 % ACN in 15 minutes. Detection was 
done using ESI-TOF-MS. 
Replicate Standard (STD) 
Post-column 
standard (PC.STD)
Area ratio 
(STD/PC.STD) 
  Area Rt [min] Area Rt [min]  
1 1985 12.49 1397 14.91 1.4209 
2 2056 12.51 1406 15.15 1.4623 
3 2700 12.42 1764 15.21 1.5306 
4 2828 12.42 1977 14.95 1.4305 
AVG 2392 12.46 1636 15.06 1.4611 
STD 433 0.05 284 0.15 0.0496 
RSD (%) 18 0.4 17 0.98 3.4 
 
 
2. Quantification 
The length of the f.s. tubing to the SPE column on the carousels varied somewhat for 
each SPE. Therefore only one of the SPE columns was used to quantify the analyte. The 
analysis of the target analyte was performed by heart-cutting a fractions from the first 
dimension. Prior to analysis of the microdialysates, bradykinin was injected onto the 
HILIC column to confirm the retention and determine in which time internal to perform 
the collection of the heart-cut fraction (see figure 19). The heart-cut was done from 19 to 
24.5 minutes. To examine that the SPE on the carousel could handle large loading 
volumes bradykinin was heart-cut performed using a 4.5 and 10 minute capturing time 
(table 6). 
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Figure 19. Chromatography of 2 µg bradykinin in the first dimension using the final 
instrumental arrangement and gradient program (n=3), as described in section 2.4.2. 
Heart-cutting from 19 to 24.5 minutes was performed. 
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Figure 20. Second dimension separation of one of the heart-cut fractions from a 
microdialysate. EIC and mass spectra of bradykinin mass spectrum originating from the 
sample and standard are presented. Chromatographic conditions as described in section 
2.4.3. 
 
The +3 ion [M+3H]3+ with m/z 354.2 was uses for quantification of bradykinin as it had a 
S/N three times the +2 ion [M+2H]2+ with m/z 530.8 (see Figure 20). 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
PC.STD. 
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Table 6. 2 µL 1 mg/mL bradykinin eluted through the first dimension and captured over different 
time interval and then eluted through the second dimension. Gradient (85 to 45 % ACN 
containing 10 mM NH4Ac) time in the first dimension was 30 minutes. Gradient (linear 5 to 50 % 
ACN containing 0.1 % f.a.) in second dimension was 15 minutes. Detection performed with UV 
at 220 nm. 
  Area 1st dim Area 2nd dim Recovery n 
RUN #1 (4.5 min) 3296332 3158316 0.9581 1 
RUN #2 (10 min) 3082878 3030081 0.9829 1 
Ratio (#2 / #1) 0.9352 0.9594   
 
 
b. Application 
The microdialysates were subjected to analysis as described in section 2.4. The samples 
were centrifuged prior to analysis. Filtering was avoided because of potential adsorption 
of sample to the filter medium. The analyte mass and concentration in the dialysates 
calculated from the acquired data is presented in table 7 (Appendix 6.3). Two of the 
samples (R3 and 26R3) had a volume of ~300 µL. Therefore the injected volume R3 and 
26R3 was 160 µL and 230 µL, respectively. 
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Table 7. Absolute masses and concentration levels of bradykinin in the microdialysis samples. 
300 µL of both R3 and 26R3 was available therefore lower volumes were injected. 
 
Sample 
Analyte mass 
[ng] 
Analyte conc. in 
sample [ng/mL] 
 
CL1 NA NA  
CL2 0.5730 0.1919  
CL3 2.8682 0.9609  
R1 3.3651 1.1273  
R2 0.8674 0.2906  
R3 0.6182 0.0989 ← injected 160 µL 
L1 0.7752 0.2597  
L2 1.5501 0.5193  
L3 0.4260 0.1427  
26L1 0.2278 0.0763  
26L2 0.4499 0.1507  
26L3 0.2609 0.0874  
26R1 0.2040 0.0683  
26R2 0.1425 0.0478  
26R3 0.0752 0.0173 ← injected 230 µL 
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c. Method evaluation 
 
The limit of detection (LOD) was defined as the concentration providing a signal which 
was three times the noise level (S/N = 3) (see Figure 21), and the limit of quantification 
(LOQ) providing S/N = 10. 50 pg (2µL, 25 ng/mL) bradykinin was introduced onto the 
PLRP column and detected in the MS yielding a response with approximately S/N = 3. 
The mass limit of detection (mLOD) was estimated to be 50 pg. With a 335 µL sample 
loop the concentration limit of detection (cLOD) of bradykinin in microdialysates is 0.15 
ng/mL. Values for mLOD, cLOD, mLOQ and cLOQ are presented in table 8. 
  
 Figure 21. EIC of bradykinin at the approximate limit of detection (0.15 ng 
 analyte/mL microdialysates), using a 335 µL loop. 
 
Time
2.50 5.00 7.50 10.00 12.50 15.00 17.50 20.00
%
0
100
EIC of m/z 354.2 
(bradykinin) 
 52
  Table 8. Limit of detection and limit of quantification. 
  Injection volume 335 µL. 
Limits of detection Value
mLOD [pg] 50 
cLOD [ng/mL] 0.15
mLOQ [pg] 167
cLOQ [ng/mL] 0.50
 
 
Seven of the samples have calculated concentration values which fall below the cLOD. 
This is most probably a consequence of the fact that the calibration curve was established 
using only the second dimension, thus the calibration curve is valid only for the second 
dimension. The quantification method used is dependent on correct loop volumes. Since 
the 2 µL loop used for calibration represented the total sample volume of 335 µL, a small 
deviation from 2 µL gives an even greater deviation with respect to the 335 µL sample. 
Because all loop volumes have uncertainties, a greater loop than 2 µL would reduce the 
error. A more correct method would be to subject the calibration standards to both 
dimensions before recording the areas. This was not carried out due to time limitations. 
Although the applied quantification method yields inaccurate results, the relative values 
will be correct. 
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4. CONCLUSION 
 
The present study has shown that the developed online µSPE-2D-capLC method coupled 
to ESI-TOF-MS detection provides high resolving power and potential to identity great 
number of peptides in a dialysates solution without extensive sample preparation. The 
flexibility to vary the fractionation according to the need is of great value in 2D 
comprehensive analysis. The employment of multiple online SPE columns for collecting 
fractions provides simplicity and flexibility as the entire sample can be captured in one 
operation and transported to other locations.  
The developed quantification method was not suitable for accurate determination of 
target analytes due to the statements in section 3.2c, although values in relation to each 
other provided will be true. Future work with this method should include a more correct 
quantification technique and further optimization. A great variety of sample material can 
be analyzed using this method, and will hopefully be executed in future projects. 
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6. APPENDIX 
6.1 Comprehensive analysis 
 
 
Table 9. Apo A separated individually on a PLRS (3µm, 300 Å) column (0.3 x 150 mm) 
and a ZIC-HILIC (5 µm, 200 Å). Sample introduced by column switching using 5 µL 
loop and loading MP ACN/H20 (5/95, v/v) containing 0.1 % f.a. Chromatographic 
conditions, HILIC; as in figure 8 using 30 minute gradient, PLRP; Gradient ran from 5 to 
50 % ACN in 15 minutes. Detection for both dimensions was ESI-TOF-MS. The marked 
m/z values originate from the compound not retained on the HILIC column. 
 
ion mass charge m/z RP HILIC 
   Rt [min] Rt [min] 
1463 2 732.5 12.67 2.22
1611.8 2 806.9 13.21 10
1251.6 2 626.8 11.57 12.22
841.4 2 421.7 10.01 13.63
830.4 2 416.2 8.09 14.2
1379.8 2 690.9 11.06 14.93
1214.6 2 608.3 8.99 15.57
868.6 2 435.3 10.75 18.84
1151.6 2 576.8 8.29 20.42
429.3 1 430.3 4.36 11.72
731.5 1 732.5 12.67 12.69
1298.64 2 650.32 11.39 13.61
1157.6 2 579.8 8.73 17.06
NA NA 386.87 8.79 2.13
1058.6 2 530.3 11.92 17.19
1011.628 2 506.814 9.92 18.49
1148.668 2 575.334 10.33 21.13
872.4 2 437.2 7.8 16.54
614.4 2 308.2 8.46 11.44
387.2 1 388.2 9.59 2.29
343.3 1 344.3 9.17 2.31
431.3 1 432.3 10.35 2.24
475.3 1 476.3 11.63 2.22
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6.2 Calibration curve 
 
 
Table 10. Areas of standards when eluted through PLRS-S using the stepped gradient 
used in the second dimension, as described in section 2.4.2. The values +2 and +3 
correspond to bradykinin ions detected with m/z 530.8 and 354.2, respectively. 
Standard ion charge, STD [Area] 
STD. PC.STD. +2 +3 +2 and +3
10 2.5 428 2130 2558
5 2.5 644 3249 3893
0.5 2.5 81 538 619
0.05 2.5 33 182 215
    Ratio [STD/PC.STD] 
STD. PC.STD. +2 +3 +2 and +3
10 2.5 3.479675 4.111969 3.990640
5 2.5 4.025000 4.576056 4.474713
0.5 2.5 0.653226 0.863563 0.828648
0.05 2.5 0.235714 0.284375 0.275641
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6.3 Target analysis 
 
 
Table 11. Areas of standards and microdialysis samples and ratios, together with 
calculated bradykinin mass amount and dialysis solution concentration. Integration of the 
EIC peaks of the +3 ion with m/z 354.2 was done. 
  
Sample (S) [Area] 
PC.STD. 
[Area] 
Ratio 
[S/PC.STD]
Mass 
amount 
[ng] 
Concentration 
[ng/mL] 
CL1      
CL2 337 624 0.54006 0.5730 0.1919 
CL3 1942 733 2.64939 2.8682 0.9609 
R1 2583 831 3.10830 3.3651 1.1273 
R2 939 1172 0.80119 0.8674 0.2906 
R3 691 1210 0.57107 0.6182 0.0989 
L1 681 951 0.71609 0.7752 0.2597 
L2 945 660 1.43182 1.5501 0.5193 
L3 373 948 0.39346 0.4260 0.1427 
26L1 182 865 0.21040 0.2278 0.0763 
26L2 293 705 0.41560 0.4499 0.1507 
26L3 134 556 0.24101 0.2609 0.0874 
26R1 111 589 0.18846 0.2040 0.0683 
26R2 111 843 0.13167 0.1425 0.0478 
26R3 79 1137 0.06948 0.0752 0.0173 
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6.4 Preliminary experiments 
 
Chromatogram of a solution of different peptides injected onto the SCX PolyLC column 
(0.5 x 125 mm). The solution contained 0.1 mg/mL Angiotensin II, 0.05 mg/mL 
bradykinin, 0.1 mg/mL leucine enkepahline, 5 µg/mL oxytocin and 0.2 mg/mL TRH. 
  
 
Figure 22. Uracil, leucine enkephaline and angiotensin II. Increasing injection volume: 5μL 
(ORANGE), 15μL (PINK), 30μL (BLUE), 100μL (GREEN) in water and 100μL (BLACK) in 
90% Ringer acetate. A gradient (Solvent A 75% water, 25% ACN, 0.1% TFA at pH 2, Solvent B 
A containing 500mM NaCl) was run from 2% to 100% B in 10 minutes. Mobile phase delivered 
at a flow of 20 µL/min. UV detection at 254nm.  
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6.5 TOF-MS operating parameters 
Table 12. Screen dumps from MassLynx tunepage showing the MS parameters. 
 
 
 
